Načítá se...
Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders
Genetic defects in complement regulatory proteins can lead to severe renal diseases, including atypical hemolytic uremic syndrome and C3 glomerulopathies, and age-related macular degeneration. The majority of the mutations found in patients with these diseases affect the glycoprotein complement fact...
Uloženo v:
| Vydáno v: | J Am Soc Nephrol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Nephrology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5407710/ https://ncbi.nlm.nih.gov/pubmed/27932477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015070745 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|